National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

lutetium Lu 177 monoclonal antibody J591
A radioimmunoconjugate consisting of a humanized monoclonal antibody directed against the extracellular domain of prostate-specific membrane antigen linked to a beta-emitting radioisotope (lutetium-177). This radioimmunoconjugate binds to tumor cells that express the extracellular domain of prostate-specific membrane antigen, delivering beta particle radiation selectively to tumor cells expressing this antigen and so limiting the exposure of normal tissues to ionizing radiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:Lu 177 MOAB J591



Previous:Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, lurtotecan, Luteohormone
Next:lutetium Lu 177-capromab, lutetium Lu-177-DOTA-chimeric monoclonal antibody cG250, Lutex, Lutrin, LV.IL-2/B7.1-transduced AML blast vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov